High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis

Arthritis and Rheumatism

Volumn 46, Issue 10, 2002, Pages 2598-2603

  Kokkola, R ^a   Sundberg, E ^a   Ulfgren, A K ^a   Palmblad, K ^a   Li, J ^a   Wang, H ^b   Ulloa, L ^b   Yang, H ^b   Yan, X J ^b   Furie, R ^b   Chiorazzi, N ^b   Tracey, K J ^b   Andersson, U ^a   Harris, H Erlandsson ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Astrid Lindgren’s Children’s Hospital ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; SALAZOSULFAPYRIDINE;

ADJUVANT ARTHRITIS; ADULT; AGED; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CARTILAGE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DRUG TARGETING; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MAMMAL CELL; MONONUCLEAR PHAGOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; RAT STRAIN; RHEUMATOID ARTHRITIS; STAINING; SYNOVIAL FLUID; SYNOVIOCYTE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BIOPSY; FEMALE; HMGB1 PROTEIN; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; OSTEOARTHRITIS; RATS; RATS, INBRED LEW; SYNOVIAL MEMBRANE; SYNOVITIS;

EID: 0036822347     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10540     Document Type: Article

References (19)

1. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999;19:5237-46.
2. Calogero S, Grassi F, Aguzzi A, Voigtlander T, Ferrier P, Ferrari S, et al. The lack of chromosomal protein Hmgl does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat Genet 1999;22:276-80.
3. Vaccari T, Beltrame M, Ferrari S, Bianchi ME. Hmg4, a new member of the Hmg1/2 gene family. Genomics 1998;49:247-52.
4. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248-51.
5. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000;405:354-60.
6. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000;192:565-70.
7. Muller S, Scaffidi P, Degryse B, Bonaldi T, Ronfani L, Agresti A, et al. New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J 2001;20:4337-40.
8. Scaffidi P, Misteli T, Bianchi ME. The release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191-5.
9. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J Biol Chem 1995;270:25752-61.
10. Schmidt AM, Yan SD, Yan SF, Stern DM. The biology of the receptor for advanced glycation end products and its ligands. Biochem Biophys Acta 2000;1498:99-111.
11. Huttunen HJ, Fages C, Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999;274:19919-24.
12. Ahmed M, Bjurholm A, Schultzberg M, Theodorsson E, Kreicbergs A. Increased levels of substance P and calcitonin gene-related peptide in rat adjuvant arthritis: a combined immunohistochemical and radioimmunoassay analysis. Arthritis Rheum 1995;38:699-709.
13. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. Hart DJ, Spector TD. The classification and assessment of osteoarthritis. Baillieres Clin Rheumatol 1995;9:407-32.
15. Åkerlund K, Erlandsson Harris H, Tracey KJ, Wang H, Fehniger T, Klareskog L, et al. Anti-inflammatory effects of a new tumor necrosis factor-alpha (TNF-α) inhibitor (CNI-1493) in collagen-induced arthritis (CIA) in rats. Clin Exp Immunol 1999;115:32-41.
16. Ulfgren AK, Andersson U, Engström M, Klareskog L, Maini RN, Taylor PC. Systemic anti-tumor necrosis factor α therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor a synthesis. Arthritis Rheum 2000;43:2391-6.
17. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000;165:2950-4.
18. Degryse B, Bonaldi T, Scaffidi P, Muller S, Resnati M, Sanvito F, et al. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 2001;152:1197-206.
19. Parkkinen J, Rauvala H. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin: enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J Biol Chem 1991;266:16730-5.